KPRX KIORA PHARMACT

NASDAQ
$2.63

KIORA PHARMACT (KPRX) is expected to report earnings on November 6, 2026, before the market open.

KIORA PHARMACT Reported Earnings
Friday, August 7, 2026 · 12:00 AM ET
Earnings Date
Nov 6
Friday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About KIORA PHARMACT

Kiora Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company. It involved in developing and commercializing products for treating ophthalmic diseases. The company's product pipeline includes KIO-301, KIO-101 and KIO-201. Kiora Pharmaceuticals Inc., formerly known as EyeGate Pharmaceuticals Inc., is based in SALT LAKE CITY.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.